Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER‐medicare analysis

Outcomes have improved considerably in multiple myeloma (MM), but disparities among racial‐ethnic groups exist. Differences in utilization of novel therapeutics are likely contributing factors. We explored such differences from the SEER‐Medicare database. A utilization analysis of lenalidomide, thal...

Descripción completa

Detalles Bibliográficos
Autores principales: Ailawadhi, Sikander, Frank, Ryan D., Advani, Pooja, Swaika, Abhisek, Temkit, M'hamed, Menghani, Richa, Sharma, Mayank, Meghji, Zahara, Paulus, Shumail, Khera, Nandita, Hashmi, Shahrukh K., Paulus, Aneel, Kakar, Tanya S., Hodge, David O., Colibaseanu, Dorin T., Vizzini, Michael R., Roy, Vivek, Colon‐Otero, Gerardo, Chanan‐Khan, Asher A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727310/
https://www.ncbi.nlm.nih.gov/pubmed/29105343
http://dx.doi.org/10.1002/cam4.1246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727310/
https://www.ncbi.nlm.nih.gov/pubmed/29105343
http://dx.doi.org/10.1002/cam4.1246

Ejemplares similares